Balancing Tissue and Tumor Formation in Regenerative Medicine-Reference-Cited by-同舟云学术

Balancing Tissue and Tumor Formation in Regenerative Medicine

Published:2012-08-15 Issue:147 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Bailey Alexander M.¹

Affiliation:

1. Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, FDA, Rockville, MD 20852, USA.

Abstract

A set of general principles can guide preclinical testing strategies for evaluating the tumorigenicity of regenerative medicine products.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference9 articles.

1. Embryonic Stem Cell Lines Derived from Human Blastocysts

2. Setting Standards for Human Embryonic Stem Cells

3. What Is the Oncologic Risk of Stem Cell Treatment for Heart Disease?

4. Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis

5. Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals Center for Biologics Evaluation and Research (CBER) FDA (1993). http://www.fda.gov/downloads/biologicsbloodvaccines/safetyavailability/ucm162863.pdf.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of eye banking with cell-based therapies;Current Opinion in Ophthalmology;2023-04-25

2. Engineering autonomous closed-loop designer cells for disease therapy;iScience;2022-03

3. Preclinical assessment of thrombin‐preconditioned human Wharton’s jelly‐derived mesenchymal stem cells for neonatal hypoxic‐ischaemic brain injury;Journal of Cellular and Molecular Medicine;2021-10-15

4. Corneal supply and the use of technology to reduce its demand: A review;Clinical & Experimental Ophthalmology;2021-08-05

5. Multisite studies for validation and improvement of a highly efficient culture assay for detection of undifferentiated human pluripotent stem cells intermingled in cell therapy products;Cytotherapy;2021-02